Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03864146 · ClinicalTrials.gov registry record · NA
Pioglitazone for the Treatment of Alcohol Use Disorder
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
NCT03864146: Completed NA study, sponsored by VA Office of Research and Development.
NCT03864146 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 201 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03864146, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
Study Summary
Alcohol Use Disorder (AUD) is common among Veterans but medication treatment is used infrequently and the impact of these treatments are small to moderate at best. Pioglitazone, a medication FDA approved for diabetes, has been shown in pre-clinical studies to reduce alcohol. The proposed study will test the efficacy of pioglitazone to reduce alcohol use in a double-blind placebo controlled trial. Investigators plan to compare pioglitazone to placebo in 200 Veterans who have an AUD and who are currently drinking alcohol at two Veterans Affairs Health Care Centers. The primary hypothesis is that Veterans with an AUD who are currently drinking alcohol will have a greater reduction in alcohol use following treatment with pioglitazone compared to those treated with placebo.
Interventions
- BEHAVIORAL Brief Behavioral Compliance Enhancement Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2019-07-17 |
| Est. Completion | 2024-03-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03864146
The ClinicalTrials.gov registry entry for NCT03864146 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief Behavioral Compliance Enhancement Treatment is the first listed.
NCT03864146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03864146 about?
NCT03864146 is a clinical study titled "Pioglitazone for the Treatment of Alcohol Use Disorder". Alcohol Use Disorder (AUD) is common among Veterans but medication treatment is used infrequently and the impact of these treatments are small to moderate at best. Pioglitazone, a medication FDA approved for diabetes, has been shown in pre-clinical studies to reduce alcohol. The proposed study will ...
What is the current status of trial NCT03864146?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2019-07-17. Estimated completion is 2024-03-29.
What interventions are being tested in trial NCT03864146?
The interventions under investigation include: Brief Behavioral Compliance Enhancement Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03864146?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.